Cargando…
Therapeutic Targeting of Exportin-1 in Childhood Cancer
SIMPLE SUMMARY: Exportin-1 is a nuclear transport protein that is overexpressed in cancer cells and associated with inferior outcomes across a range of malignancies. Selinexor is a novel FDA-approved inhibitor of Exportin-1 (XPO1). Although significant research has focused on integration of selinexo...
Autores principales: | Galinski, Basia, Alexander, Thomas B., Mitchell, Daniel A., Chatwin, Hannah V., Awah, Chidiebere, Green, Adam L., Weiser, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699059/ https://www.ncbi.nlm.nih.gov/pubmed/34944778 http://dx.doi.org/10.3390/cancers13246161 |
Ejemplares similares
-
Structural Basis of Targeting the Exportin CRM1 in Cancer
por: Dickmanns, Achim, et al.
Publicado: (2015) -
Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic
Target for Neuroblastoma
por: Pan, Li-Jia, et al.
Publicado: (2021) -
Importins and exportins in cellular differentiation
por: Okada, Norihisa, et al.
Publicado: (2008) -
Exportin 1 inhibition as antiviral therapy
por: Uddin, Md. Hafiz, et al.
Publicado: (2020) -
Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
por: Cotul, Eylem Kulkoyluoglu, et al.
Publicado: (2020)